The medtech industry is evolving more quickly than ever, spurred along by lessons learned from the COVID-19 pandemic, an increasingly digital-friendly patient population and tech developments that are bringing artificial intelligence, augmented and virtual reality and other once-futuristic concepts firmly into the present. That rapidly shifting landscape has created an especially Darwinian environment, one in which […]

CFOs of early-stage biotechnology firms get a lot of practice in the art of raising money. No matter the market cycle, they must find capital to fund costly research that will ideally lead to new drugs or treatments that generate revenue — and turn them cash-flow positive. Finance chiefs at pre-revenue companies must tamp down cash-burn as […]

Reneo Pharmaceuticals (NASDAQ:RPHM) is conducting a pivotal Phase 2b clinical trial with its lead asset, REN001, in a rare genetic disease that predominately affects skeletal muscle and reduces life expectancy, with topline data expected in the fourth quarter of 2023. “We believe REN001 is a pipeline in a pill to treat a host of diseases involved […]